RAND Corp. tells Congress that Bid Protests are Not a Problem
Client Alert | 1 min read | 01.05.18
RAND Corp. recently submitted a report to Congress on the effects of Department of Defense bid protests, as required by the 2017 NDAA. Interestingly, RAND found:
- Bid protests are not a significant impediment, as some in Congress have suggested. To the contrary, “bid protests are exceedingly uncommon for DoD procurements.”
- GAO’s 100-day deadline should stay. GAO already resolves 70% of protests within 60 days, and often needs the full 100 days for complex protests and numerous end of fiscal year protests.
- Task order protests are important. The higher effectiveness rate for task order protests indicates that such procurements may be more problematic and should be protestable.
- A majority of protests are brought by small businesses. Congress should consider approaches to reduce and improve such protests.
- Debriefings matter. “Evasive or adversarial debriefings may lead to a bid protest in most cases.”
RAND also recommended improving DoD recordkeeping to support future studies.
Contacts
Insights
Client Alert | 4 min read | 01.07.26
On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026.
Client Alert | 3 min read | 01.07.26
CMMC for AI? Defense Policy Law Imposes AI Security Framework and Requirements on Contractors
Client Alert | 3 min read | 01.07.26
New Year, Same CIPA Uncertainty – When Will the Appellate Courts Enter the Chat?
Client Alert | 11 min read | 01.07.26
